48592 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 21
00:36 UTC
|
SAIL
SailPoint
|
◎ Target | Meta Marshall ★★★★☆ #466 | Overweight | $18.00→ $22.00+22.2% |
|
Aug 21
00:36 UTC
|
S
SentinelOne
|
◎ Target | John DiFucci ★★★★★ #47 | Buy | $24.00→ $28.00+16.7% |
|
Aug 21
00:36 UTC
|
S
SentinelOne
|
◎ Target | Saket Kalia ★★★★★ #120 | Equal Weight | $16.00→ $22.00+37.5% |
|
Aug 21
00:36 UTC
|
S
SentinelOne
|
◎ Target | Jonathan Ruykhaver ★★★★★ #81 | Overweight | $24.00→ $26.00+8.3% |
|
Aug 21
00:36 UTC
|
RLAY
Relay Therapeutics
|
◎ Target | Robert Burns ★☆☆☆☆ #2990 | Buy | $28.00→ $29.00+3.6% |
|
Aug 21
00:36 UTC
|
RBRK
Rubrik
|
◎ Target | Jonathan Ruykhaver ★★★★★ #81 | Overweight | $95.00→ $120.00+26.3% |
|
Aug 21
00:36 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Whitney Ijem ★★☆☆☆ #2848 | Buy | $81.00→ $83.00+2.5% |
|
Aug 21
00:36 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2794 | Buy | $45.00→ $58.00+28.9% |
|
Aug 21
00:36 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Kristen Kluska ★☆☆☆☆ #3079 | Overweight | $96.00→ $103.00+7.3% |
|
Aug 21
00:36 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Benjamin Burnett ★★★☆☆ #1786 | Overweight | $45.00→ $46.00+2.2% |
|
Aug 21
00:36 UTC
|
PNTG
The Pennant Group
|
◎ Target | Ben Hendrix ★★★★☆ #571 | Outperform | $42.00→ $44.00+4.8% |
|
Aug 21
00:36 UTC
|
PGR
Progressive
|
◎ Target | Elyse Greenspan ★★★★☆ #446 | Underweight | $198.00→ $201.00+1.5% |
|
Aug 21
00:36 UTC
|
PD
PagerDuty
|
◎ Target | Joel Fishbein not yet tracked | Buy | $11.00→ $13.00+18.2% |
|
Aug 21
00:36 UTC
|
PCTY
Paylocity
|
◎ Target | Jared Levine ★★★★★ #125 | Buy | $168.00→ $177.00+5.4% |
|
Aug 21
00:36 UTC
|
OPRA
Opera
|
◎ Target | Naved Khan ★★★★★ #158 | Buy | $27.00→ $28.00+3.7% |
|
Aug 21
00:36 UTC
|
OMG
Omai Gold Mines
|
◎ Target | firm only | C$3.50→ C$4.25+21.4% | |
|
Aug 21
00:36 UTC
|
OKTA
Okta
|
◎ Target | Jonathan Ruykhaver ★★★★★ #81 | Overweight | $125.00→ $170.00+36.0% |
|
Aug 21
00:36 UTC
|
OKTA
Okta
|
◎ Target | Keith Bachman ★★★★★ #131 | Outperform | $120.00→ $168.00+40.0% |
|
Aug 21
00:36 UTC
|
OKTA
Okta
|
◎ Target | Simeon Gutman ★★★★☆ #873 | Overweight | $115.00→ $180.00+56.5% |
|
Aug 21
00:36 UTC
|
OKTA
Okta
|
◎ Target | John DiFucci ★★★★★ #47 | Buy | $138.00→ $162.00+17.4% |
|
Aug 21
00:36 UTC
|
NU
NU
|
◎ Target | Thiago Batista ★★★★☆ #348 | Buy | $16.90→ $18.20+7.7% |
|
Aug 21
00:36 UTC
|
NRGV
Energy Vault
|
◎ Target | Vikram Bagri ★☆☆☆☆ #2989 | Buy | $5.00→ $6.00+20.0% |
|
Aug 21
00:36 UTC
|
NIQ
NIQ Global Intelligence
|
◎ Target | Kyle Peterson ★★★☆☆ #1710 | Buy | $18.00→ $21.00+16.7% |
|
Aug 21
00:36 UTC
|
NHP
National Healthcare Properties
|
◎ Target | Wesley Golladay not yet tracked | Outperform | $17.00→ $18.00+5.9% |
|
Aug 21
00:36 UTC
|
NDSN
Nordson
|
◎ Target | Jeffrey D. Hammond not yet tracked | Overweight | $335.00→ $360.00+7.5% |
|
Aug 21
00:36 UTC
|
MRVL
Marvell Technology
|
◎ Target | Timothy Arcuri ★★★☆☆ #1748 | Buy | $300.00→ $310.00+3.3% |
|
Aug 21
00:36 UTC
|
MRT
Marti Technologies
|
◎ Target | Fawne Jiang ★☆☆☆☆ #3159 | Buy | $5.00→ $6.00+20.0% |
|
Aug 21
00:36 UTC
|
MRNA
Moderna
|
◎ Target | Eliana Merle ★★★☆☆ #1426 | Neutral | $50.00→ $150.00+200.0% |
|
Aug 21
00:36 UTC
|
MRNA
Moderna
|
◎ Target | Terence Flynn ★★★★☆ #831 | Equal Weight | $39.00→ $89.00+128.2% |
|
Aug 21
00:36 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Michael Yee ★★★☆☆ #1150 | Buy | $145.00→ $175.00+20.7% |
|
Aug 21
00:36 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Evan David Seigerman not yet tracked | Outperform | $142.00→ $170.00+19.7% |
|
Aug 21
00:36 UTC
|
MRCY
Mercury Systems
|
◎ Target | Alexandra Mandery not yet tracked | Buy | $109.00→ $120.00+10.1% |
|
Aug 21
00:36 UTC
|
MRCY
Mercury Systems
|
◎ Target | Austin Moeller ★☆☆☆☆ #3171 | Buy | $106.00→ $128.00+20.8% |
|
Aug 21
00:36 UTC
|
MDB
MongoDB
|
◎ Target | Keith Bachman ★★★★★ #131 | Outperform | $375.00→ $500.00+33.3% |
|
Aug 21
00:36 UTC
|
MDB
MongoDB
|
◎ Target | Miller Jump ★★★★★ #78 | Buy | $400.00→ $475.00+18.8% |
|
Aug 21
00:36 UTC
|
MAR
Marriott International
|
◎ Target | Robin Farley not yet tracked | Neutral | $412.00→ $395.00-4.1% |
|
Aug 21
00:36 UTC
|
LZB
La-Z-Boy
|
◎ Target | Bradley B. Thomas not yet tracked | Overweight | $46.00→ $40.00-13.0% |
|
Aug 21
00:36 UTC
|
LUN
Lundin Mining
|
◎ Target | firm only | Buy | C$44.00→ C$42.00-4.5% |
|
Aug 21
00:36 UTC
|
LOW
Lowe's Companies
|
◎ Target | Steven Zaccone ★★★★☆ #713 | Buy | $267.00→ $260.00-2.6% |
|
Aug 21
00:36 UTC
|
LOW
Lowe's Companies
|
◎ Target | David Bellinger ★★★☆☆ #1240 | Outperform | $280.00→ $250.00-10.7% |
|
Aug 21
00:36 UTC
|
LOW
Lowe's Companies
|
◎ Target | Michael Lasser ★★★★☆ #959 | Buy | $285.00→ $275.00-3.5% |
|
Aug 21
00:36 UTC
|
LOW
Lowe's Companies
|
◎ Target | Scot Ciccarelli ★★★★☆ #910 | Buy | $255.00→ $254.00-0.4% |
|
Aug 21
00:36 UTC
|
LOW
Lowe's Companies
|
◎ Target | Joseph Feldman not yet tracked | Outperform | $280.00→ $260.00-7.1% |
|
Aug 21
00:36 UTC
|
LOGI
Logitech International
|
◎ Target | Joseph Cardoso ★★★☆☆ #1139 | Neutral | $120.00→ $102.00-15.0% |
|
Aug 21
00:36 UTC
|
LNSR
LENSAR
|
◎ Target | Ryan Zimmerman ★★★☆☆ #1717 | Buy | $9.00→ $10.00+11.1% |
|
Aug 21
00:36 UTC
|
KMR
Kenmare Resources
|
◎ Target | firm only | Hold | GBX 220→ GBX 210-4.5% |
|
Aug 21
00:36 UTC
|
KIDS
OrthoPediatrics
|
◎ Target | Ryan Zimmerman ★★★☆☆ #1717 | Buy | $24.00→ $29.00+20.8% |
|
Aug 21
00:36 UTC
|
JKHY
Jack Henry & Associates
|
◎ Target | Timothy Chiodo ★★★★☆ #362 | Neutral | $165.00→ $170.00+3.0% |
|
Aug 21
00:36 UTC
|
JKHY
Jack Henry & Associates
|
◎ Target | Nik Cremo ★★★☆☆ #1416 | Overweight | $170.00→ $185.00+8.8% |
|
Aug 21
00:36 UTC
|
JKHY
Jack Henry & Associates
|
◎ Target | Will Nance ★★★★☆ #886 | Neutral | $158.00→ $178.00+12.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.